| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.6 / 5 (542) | Istanbul, Turkey | 49+ years3,000+ treatments | Biological therapy, bone marrow transplantation, immunotherapy with Keytruda, chemotherapy | Advanced or refractory Hodgkin's lymphoma | Offers autologous bone marrow transplants with a high success rate. Clinic has performed 3,000+ transplants and is led by a professor trained at top institutions like MD Anderson. | Planetree's Gold Certificate, International Accreditation System for Interventional Oncology Services (IASIOS) | ||
| #2 | 4.5 / 5 (263) | Istanbul, Turkey | 33+ years | Biological therapy, bone marrow transplantation, chemotherapy (HDAC, FLAG-IDA), autologous bone marrow transplant | Advanced or recurrent Hodgkin's lymphoma | Specializes in bone marrow transplants with HEPA-filtered rooms. Offers advanced chemotherapy regimens. JCI accredited for treatment safety. | Joint Commission International , Turkish Medical Association (Türk Tabıplerı Bırliği) | ||
| #3 | 4.6 / 5 (165) | Istanbul, Turkey | 27+ years | Biological therapy, bone marrow transplantation, immunotherapy with Keytruda (Pembrolizumab) | Advanced or recurrent Hodgkin's lymphoma | Specializes in hematology with JCI accreditation. Offers Keytruda immunotherapy and bone marrow transplants. Hematologist has performed 900+ procedures. | International Organization for Standardization, Joint Commission International | ||
| #4 | 4.6 / 5 (432) | Istanbul, Turkey | 11+ years | Biological therapy, bone marrow transplantation, immunotherapy with Keytruda (Pembolizumab), chemotherapy using ABVD protocol | Relapsed or advanced Hodgkin's lymphoma | Offers autologous and allogeneic bone marrow transplants with 80-90% success rate. Specializes in advanced therapies like Keytruda. Follows international NCCN and ESMO protocols. | International Organization for Standardization, Joint Commission International | ||
| #5 | 4.6 / 5 (151) | Antalya, Turkey | — | — | Biological therapy, bone marrow transplantation, immunotherapy with Keytruda (Pembrolizumab), chemotherapy, targeted therapy, radiotherapy | Patients needing advanced immunotherapy | Offers Keytruda immunotherapy for Hodgkin's lymphoma. Uses TrueBeam STx radiotherapy to target tumors precisely. JCI accredited with a multidisciplinary oncology team. | Joint Commission International | |
| #6 | 4.8 / 5 (10) | Ankara, Turkey | — | — | — | — | — | ||
| #7 | 5.0 / 5 (58) | Istanbul, Turkey | 12+ years | Biological therapy, bone marrow transplantation, ABVD chemotherapy, Brentuximab Vedotin, Bendamustine | Advanced or resistant Hodgkin's lymphoma | Offers ABVD chemotherapy and advanced options like Brentuximab Vedotin for resistant cases. JCI-accredited facility with specialized hematology team. Includes PET-CT scans for treatment monitoring. | Joint Commission International , International Organization for Standardization | ||
| #8 | 4.8 / 5 (9) | Istanbul, Turkey | 11+ years | Chemotherapy, radiotherapy, immunotherapy, bone marrow transplant, PET-CT staging | Patients seeking access to clinical research | Chemotherapy for over 40 patients at once. Multidisciplinary tumor board with nine specialties designs each plan, backed by a Clinical Research Unit offering access to emerging global treatments. | — | ||
| #9 | 4.5 / 5 (55) | Istanbul, Turkey | 35+ years | Biochemical blood analysis | — | — | Joint Commission International | ||
| #10 | 4.6 / 5 (7) | Antalya, Turkey | 36+ years | — | — | — | International Health Tourism Authorization Certificate |